BAC
Bank of America Corporation
BAC has the edge over COHN overall, supported by lower modeled downside and stronger modeled upside.
COHN
Cohen & Company Inc.
COHN offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
COHN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
COHN's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like COHN.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over COHN in the historical PE scenario, which offers more potential upside but is not a forecast.
COHN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 1.2x | $2.61 | -73% |
| Fair | 2.4x | $5.37 | -44% |
| Expensive | 3.3x | $7.52 | -21% |
| Current | 4.2x | $9.52 | — |
Historical ranges are pointers, not guarantees.
COHN's PE is in its expensive range at 4.2x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
COHN Forward outlook
There aren't enough analyst estimates for COHN to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus COHN down 46%.
COHN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | $4.13 | +$12.32 |
| Q2 2024 | $2.54 | +$11.09 |
| Q1 2024 | -$0.33 | +$5.41 |
| Q4 2023 | -$3.38 | +$6.05 |
COHN's earnings per share have fallen from their peak: $2.25 over the past year, against $17.86 in mid-2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over COHN on profitability, with a higher operating margin.
COHN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.4M | -61% |
| Q2 2026 | $69.5M | +16% |
| Q1 2026 | $57.9M | +101% |
| Q4 2025 | $102.7M | +454% |
| Q3 2025 | $84.2M | +166% |
| Q2 2025 | $59.9M | +454% |
| Q1 2025 | $28.7M | +55% |
| Q4 2024 | $18.5M | -46% |
COHN's revenue is growing: $32M last quarter, down 61% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.1% | -18 points |
| Q2 2026 | 18% | +5.3 points |
| Q1 2026 | 8.9% | +8.5 points |
| Q4 2025 | 29% | +59 points |
| Q3 2025 | 26% | +3.1 points |
| Q2 2025 | 13% | +72 points |
| Q1 2025 | 0.4% | +19 points |
| Q4 2024 | -30% | -63 points |
COHN's operating margin was 8.1% last quarter, down 18 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over COHN on cash generation, producing positive trailing cash flow while its opponent burns cash.
COHN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $27.5M | +24% |
| Q2 2026 | $3.7M | -71% |
| Q1 2026 | -$31.5M | -$25M |
| Q4 2025 | -$2.5M | -163% |
| Q3 2025 | $22.2M | +484% |
| Q2 2025 | $12.9M | +$17.5M |
| Q1 2025 | -$6.5M | -230% |
| Q4 2024 | $4M | +$7.5M |
COHN's free cash flow was −$3M over the past year, against $33M the year before. Free cash flow isn't a meaningful measure for financial services companies like COHN.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over COHN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
COHN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.3% | +145K shares |
| 1 year | +8.1% | +479K shares |
| 3 years | +347% | +5M shares |
| 5 years | +62% | +2.5M shares |
COHN has 6M diluted shares, up 8.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | $1,000 |
| Q3 2021 | $187,000 |
| Q2 2021 | $7,000 |
| Q1 2021 | $662,000 |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
COHN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | 0.7x | Very low |
| Q3 2024 | 2.2x | Moderate |
| Q1 2024 | 1.6x | Healthy |
COHN has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
COHN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.4 | Neutral |
| Stochastic | 16.4 | Oversold |
COHN's weekly RSI is 40 (neutral) and its Stochastic is 16 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
COHN PE vs Financial Services Sector
| Metric | COHN | Sector median | Relative |
|---|---|---|---|
| PE | 4.2x | 13x | 68% below |
| PE % | 95 | 63 | 32 pts above |
COHN has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over COHN on trend strength, trading above more of its moving averages.
COHN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.95 | 4.3% below |
| 20 week MA | $11.3 | 16% below |
| 50 week MA | $14.5 | 35% below |
| 100 week MA | $12.3 | 23% below |
| 200 week MA | $10.0 | 4.8% below |
COHN is in a downtrend: it's below all five of its weekly moving averages, and 4.8% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over COHN on returns for 2026, with the stronger performance.
COHN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.82 | $16.5 | +331% |
| 2021 | $16.5 | $15.6 | -5.3% |
| 2022 | $15.6 | $8.79 | -44% |
| 2023 | $8.79 | $6.65 | -24% |
| 2024 | $6.65 | $10.4 | +56% |
| 2025 | $10.4 | $17.4 | +68% |
| 2026 YTD | $17.4 | $9.52 | -45% |
COHN's yearly returns have swung widely, from +331% in 2020 to −44% in 2022. It's down 45% so far in 2026.